Pregnant woman with Eisenmenger’s syndrome (RCD code: VII-II-1A.4d)

Grzegorz Kopeć, Agata Leśniak-Sobelga, Magdalena Kaźnica-Wiatr, Anna Tyrka, Marcin Waligóra, Krzysztof Rytlewski, Piotr Podolec

Full Text:

PDF

Abstract


Pregnancy in women with pulmonary arterial hypertension due to congenital heart disease is associated with significant morbidity and mortality both in the mother and fetus. We report a case of a 25-year-old woman with Eisenmenger’s syndrome who got pregnant when treated with bosentan. Bosentan was changed to sildenafil. During the course of pregnancy she developed ischemic stroke. She delivered in the 33 week of gestation. We present our treatment approach and review the current literature on pregnany in pulmonary arterial hypertension. JRCD 2013; 1 (3): 27–31


Keywords


pulmonary hypertension; congenital heart disease; pregnancy

References


Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31: 1650–1657.

Presbitero P, Somerville J, Stone S, et al. Pregnancy in cyanotic congenital heart disease. outcome of mother and fetus. Circulation 1994; 89: 2673–2676.

Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol 2000; 24: 11–14.

Ueland K. Maternal cardiovascular dynamics. VII. intrapartum blood volume changes. Am J Obstet Gynecol. 1976; 126: 671–677.

Budev MM, Arroliga AC, Emery S. Exacerbation of underlying pulmonary disease in pregnancy. Crit Care Med 2005; 33(10 Suppl): S313–318.

Midwall J, Jaffin H, Herman MV, Kupersmith J. Shunt flow and pulmonary hemodynamics during labor and delivery in the eisenmenger syndrome. Am J Cardiol 1978; 42: 299–303.

Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009; 30: 256–265.

European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: The task force on the management of cardiovascular diseases during pregnancy of the european society of cardiology (ESC). Eur Heart J 2011; 32: –3197.

Hsu CH, Gomberg‑Maitland M, Glassner C, Chen JH. The management of pregnancy and pregnancy‑related medical conditions in pulmonary arterial hypertension patients. Int J Clin Pract Suppl 2011; 172: 6–14.

Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the european respiratory society (ERS), endorsed by the international society of heart and lung transplantation (ISHLT). Eur Heart J 2009; 30: 2493–2537.

Avila WS, Grinberg M, Snitcowsky R, et al. Maternal and fetal outcome in pregnant women with eisenmenger’s syndrome. Eur Heart J 1995; 16: 460–464.

Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmenger’s syndrome and pregnancy. Obstet Gynecol Surv 1979; 34: 721–741.

Bonnin M, Mercier FJ, Sitbon O, et al. Severe pulmonary hypertension during pregnancy: Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102: 1133–1137; discussion 5A–6A.

Smedstad KG, Cramb R, Morison DH. Pulmonary hypertension and pregnancy: A series of eight cases. Can J Anaesth 1994; 41: 502–512.

Slomka F, Salmeron S, Zetlaoui P, et al. Primary pulmonary hypertension and pregnancy: Anesthetic management for delivery. Anesthesiology 1988; 69: 959–961.

Stewart R, Tuazon D, Olson G, Duarte AG. Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy. Chest 2001;119: 973–975.

Avdalovic M, Sandrock C, Hoso A, et al. Epoprostenol in pregnant patients with secondary pulmonary hypertension: Two case reports and a review of the literature. Treat Respir Med 2004; 3: 29–34.

Bildirici I, Shumway JB. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery. Obstet Gynecol ; 103(5 Pt 2): 1102–1105.

Geohas C, McLaughlin VV. Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenol. Chest 2003; 124: 1170–1173.

Badalian SS, Silverman RK, Aubry RH, Longo J. Twin pregnancy in a woman on long‑term epoprostenol therapy for primary pulmonary hypertension. A case report. J Reprod Med 2000; 45: 149–152.

Lam GK, Stafford RE, Thorp J, et al. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol 2001; 98(5 Pt 2): 895–898.

Lacassie HJ, Germain AM, Valdes G, et al. Management of eisenmenger syndrome in pregnancy with sildenafil and L‑arginine. Obstet Gynecol 2004; (5 Pt 2): 1118–1120.

Molelekwa V, Akhter P, McKenna P, et al. Eisenmenger’s syndrome in a 27 week pregnancy–management with bosentan and sildenafil. Ir Med J 2005; : 87–88.

Elliot CA, Stewart P, Webster VJ, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J 2005; 26: 168–173.

Wong PS, Constantinides S, Kanellopoulos V, et al. Primary pulmonary hypertension in pregnancy. J R Soc Med 2001; 94: 523–525.




DOI: http://dx.doi.org/10.20418%2Fjrcd.vol1no3.74

Refbacks

  • There are currently no refbacks.
Journal of Rare Cardiovascular Diseases (JRCD)
John Paul II Hospital in Kraków, 80 Prądnicka Str., 31-202 Kraków, Poland
Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88
e-mail: rarediseases@szpitaljp2.krakow.pl
Published by SoftQ sp. z o.o.
ul. Oleandry 2, 30-063 Kraków, Poland
Phone: +48 (12) 444 1650 Fax: +48 (12) 444 1659
e-mail: softq@softq.pl